Africa’s First Cell & Gene Therapy Startup Altera Biosciences Raises R29 Million
Altera Biosciences, Africa’s first dedicated cell and gene therapy biotech company, has announced the successful close of a groundbreaking R29 million pre-seed funding round.
Source: TechFinancials (link opens in a new window)
- Categories
- Health Care, Technology
